# ARHGEF16

## Overview
ARHGEF16, or Rho guanine nucleotide exchange factor 16, is a gene that encodes a protein involved in the regulation of Rho GTPases, which are pivotal in controlling various cellular processes such as cytoskeletal dynamics, cell migration, and cell cycle progression. The protein functions as a guanine nucleotide exchange factor (GEF), facilitating the exchange of GDP for GTP on Rho proteins, thereby activating them. This activation is essential for modulating the actin cytoskeleton and influencing cell morphogenesis, proliferation, invasion, and survival (Huang2018GLI2). ARHGEF16 is primarily active in the cytoplasm and is known to interact with several proteins, including Tip-1 and Elmo1, to enhance cellular signaling pathways (Lee2014Arhgef16; Oliver2010The). Its role in cancer biology, particularly in glioma and breast cancer, highlights its significance in promoting cell migration and resistance to apoptosis, making it a potential target for therapeutic interventions (Huang2018GLI2).

## Function
ARHGEF16, also known as Rho guanine nucleotide exchange factor 16, is involved in the regulation of Rho GTPases, which are critical for various cellular processes such as cytoskeletal dynamics, cell migration, and cell cycle progression. It acts by facilitating the exchange of GDP for GTP on Rho proteins, thereby activating them. This activation is crucial for the regulation of cell morphogenesis, proliferation, invasion, and survival by modulating the actin cytoskeleton (Huang2018GLI2).

In healthy human cells, ARHGEF16 is primarily active in the cytoplasm, where it plays a role in maintaining cellular structure and signaling pathways. It is involved in the activation of the Rho GTPase Cdc42, which is significant for cellular signaling pathways (Oliver2010The). The interaction between ARHGEF16 and other proteins, such as Tip-1, enhances the activation of Cdc42, which is a critical component of cell signaling pathways (Oliver2010The). This interaction is influenced by proteasomal degradation, suggesting a regulatory mechanism for its activity (Oliver2010The).

ARHGEF16's role in activating Cdc42 is significant in the context of cellular signaling and transformation, although its specific function in non-cancerous conditions is not detailed in the available literature (Oliver2010The).

## Clinical Significance
ARHGEF16, also known as Rho guanine nucleotide exchange factor 16, has been implicated in the progression of glioma, a type of brain cancer. Alterations in the expression of ARHGEF16 are associated with increased cell proliferation and migration in glioma cells. The gene is transcriptionally activated by the GLI2 transcription factor, which is part of the Hedgehog signaling pathway. This pathway is known to be dysregulated in various cancers, including glioblastoma (Huang2018GLI2). Overexpression of ARHGEF16 in glioma cells enhances their migratory and proliferative capabilities, while knockdown of the gene results in suppressed tumor growth both in vitro and in vivo (Huang2018GLI2).

The interaction between ARHGEF16 and cytoskeleton-associated protein 5 (CKAP5) further promotes cell migration and proliferation, suggesting that the GLI2/ARHGEF16/CKAP5 signaling axis is crucial for glioma progression (Huang2018GLI2). Targeting this pathway could be a potential therapeutic strategy for treating glioma, as inhibition of GLI2 with GANT61 has been shown to reduce glioma growth (Huang2018GLI2). While the study primarily focuses on glioma, ARHGEF16 has also been implicated in promoting migration and resistance to apoptosis in breast cancer cells, indicating its broader role in cancer biology (Huang2018GLI2).

## Interactions
ARHGEF16, also known as Rho guanine nucleotide exchange factor 16, is involved in several protein interactions that play crucial roles in cellular processes. It interacts with the Tax-interacting-protein 1 (Tip-1) and the HPV16 E6 oncoprotein, facilitating the activation of the Rho GTPase Cdc42. This interaction is mediated by the carboxyl PDZ binding motif of ARHGEF16 and is enhanced in the presence of HPV16 E6 and Tip-1, leading to increased Cdc42 activation (Oliver2010The).

ARHGEF16 also interacts with Elmo1, promoting the clearance of apoptotic cells via RhoG-dependent Rac1 activation. This interaction was identified through a yeast two-hybrid screen and confirmed in mammalian cells. The binding occurs at the N20R fragment of ARHGEF16, and their co-expression significantly enhances Rac1 activation, crucial for apoptotic cell clearance (Lee2014Arhgef16).

In the context of cancer, ARHGEF16 interacts with the FYN kinase, which stabilizes ARHGEF16 by inhibiting its proteasomal degradation. This interaction is essential for colon cancer cell proliferation and migration, as FYN-mediated phosphorylation of ARHGEF16 enhances its stability and activity (Yu2020FYN).


## References


[1. (Yu2020FYN) Bei Yu, Linlin Xu, Limin Chen, Yao Wang, Hongying Jiang, Yiting Wang, Yehong Yan, Shiwen Luo, and Zhenyu Zhai. Fyn is required for arhgef16 to promote proliferation and migration in colon cancer cells. Cell Death &amp; Disease, August 2020. URL: http://dx.doi.org/10.1038/s41419-020-02830-1, doi:10.1038/s41419-020-02830-1. This article has 15 citations.](https://doi.org/10.1038/s41419-020-02830-1)

[2. (Huang2018GLI2) Dengliang Huang, Yiting Wang, Linlin Xu, Limin Chen, Minzhang Cheng, Wei Shi, Huanting Xiong, Detina Zalli, and Shiwen Luo. Gli2 promotes cell proliferation and migration through transcriptional activation of arhgef16 in human glioma cells. Journal of Experimental &amp; Clinical Cancer Research, October 2018. URL: http://dx.doi.org/10.1186/s13046-018-0917-x, doi:10.1186/s13046-018-0917-x. This article has 44 citations.](https://doi.org/10.1186/s13046-018-0917-x)

[3. (Lee2014Arhgef16) Juyeon Lee, Boyeon Park, Gayoung Kim, Kwangwoo Kim, Jeongjun Pak, Kwanhyeong Kim, Michael B. Ye, Sung-Gyoo Park, and Daeho Park. Arhgef16, a novel elmo1 binding partner, promotes clearance of apoptotic cells via rhog-dependent rac1 activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(11):2438–2447, November 2014. URL: http://dx.doi.org/10.1016/j.bbamcr.2014.07.006, doi:10.1016/j.bbamcr.2014.07.006. This article has 22 citations.](https://doi.org/10.1016/j.bbamcr.2014.07.006)

[4. (Oliver2010The) A W Oliver, X He, K Borthwick, A J Donne, L Hampson, and I N Hampson. The hpv16 e6 binding protein tip-1 interacts with arhgef16, which activates cdc42. British Journal of Cancer, 104(2):324–331, December 2010. URL: http://dx.doi.org/10.1038/sj.bjc.6606026, doi:10.1038/sj.bjc.6606026. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6606026)